You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chimerism

Showing 1 - 25 of 759
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Failure, Kidney Transplant; Complications, Chimera Trial (other, procedure, drug)

Not yet recruiting
  • Kidney Failure
  • +2 more
  • Bone Marrow Transplant
  • +2 more
  • (no location specified)
Jun 9, 2023

Renal Failure Trial in Boston (Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab, Combined bone marrow

Recruiting
  • Renal Failure
  • Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab
  • Combined bone marrow and kidney transplant
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 19, 2023

Predict T Cell Chimerism After MSD SCT for SCD?

Recruiting
  • Sickle Cell Disease
  • Alemtuzumab Injection [Campath]
  • Amsterdam, Netherlands
    Amsterdam Medical Centre
Jun 20, 2023

Myeloid Chimerism Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (CliniMACS CD34 Reagent)

Recruiting
  • Myeloid Chimerism
  • CliniMACS CD34 Reagent
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 7, 2022

Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
    • Brisbane, California
    • +4 more
    Jul 18, 2022

    Myeloid Malignancy Trial in Detroit (azacitidine)

    Recruiting
    • Myeloid Malignancy
    • Detroit, Michigan
      Henry ford hospital
    Dec 23, 2021

    Intestinal Transplantation Trial in New York (Cell Therapy)

    Recruiting
    • Intestinal Transplantation
    • Cell Therapy
    • New York, New York
      Columbia University Irving Medical Center/NYP
    Dec 28, 2021

    Cell-Free Nucleic Acids Trial (Cell free DNA analysis)

    Not yet recruiting
    • Cell-Free Nucleic Acids
    • Cell free DNA analysis
    • (no location specified)
    Jan 27, 2022

    PD-1 Antibody, Mixed Chimerism Trial in Beijing (Toripalimab Injection)

    Not yet recruiting
    • PD-1 Antibody
    • Mixed Chimerism
    • Toripalimab Injection
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Jun 27, 2021

    Response Rate Trial in Shanghai (Decitabine)

    Completed
    • Response Rate
    • Shanghai, Shanghai, China
      Blood & Marrow Transplantation Center, RuiJin Hospital
    May 19, 2021

    Kidney Failure, Chronic, Renal Insufficiency Trial in Boston (drug, radiation, procedure)

    Completed
    Has Results
    • Kidney Failure, Chronic
    • Renal Insufficiency
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 4, 2021

    End Stage Renal Disease Trial in Boston (MEDI-507, Rituximab, Total Body Irradiation)

    Completed
    Has Results
    • End Stage Renal Disease
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 19, 2021

    Kidney Transplant Rejection Trial (MDR-103)

    Not yet recruiting
    • Kidney Transplant Rejection
    • MDR-103
    • (no location specified)
    Apr 4, 2022

    Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

    Recruiting
    • Sickle Cell Disease
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jul 6, 2022

    Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism Trial in Belgium, Netherlands (Mesenchymal stem

    Recruiting
    • Graft-versus-host Disease
    • +2 more
    • Mesenchymal stem cells
    • Edeghem, Antwerpen, Belgium
    • +11 more
    Sep 19, 2022

    Sickle Cell Disease, Beta Thalassemia Trial in New York (Busulfan, Fludarabine, Alemtuzumab)

    Active, not recruiting
    • Sickle Cell Disease
    • Beta Thalassemia
    • New York, New York
      Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
    Aug 12, 2021

    Sickle Cell Disease Trial in Louisville, Durham, Pittsburgh (Enriched Hematopoetic Stem Cell Infusion)

    Completed
    • Sickle Cell Disease
    • Enriched Hematopoetic Stem Cell Infusion
    • Louisville, Kentucky
    • +2 more
    Oct 6, 2020

    Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

    Not yet recruiting
    • Recurrent Severe Aplastic Anemia
    • Refractory Severe Aplastic Anemia
    • Anti-Thymocyte Globulin
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Feb 23, 2023

    Metachromatic Leukodystrophy Trial in Durham (Enriched Hematopoetic Stem Cell Infusion)

    No longer available
    • Metachromatic Leukodystrophy
    • Enriched Hematopoetic Stem Cell Infusion
    • Durham, North Carolina
      Duke University
    Oct 6, 2020

    MDS, Leukemia, Myeloid, Acute Trial in London (DLI will be administered to all patients at Month 4 (+/- 20 days) after stem cell

    Unknown status
    • Myelodysplastic Syndromes
    • Leukemia, Myeloid, Acute
    • DLI will be administered to all patients at Month 4 (+/- 20 days) after stem cell transplant regardless of peripheral blood CD3 chimerism (including if they have full donor chimerism)
    • DLI will be administered from Month 6 (+/- 20 days) after stem cell transplant according to institutional practice
    • London, United Kingdom
      King's College Hospital NHS Foundation Trust
    Apr 1, 2020

    Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

    Not yet recruiting
    • Severe Aplastic Anemia
    • (no location specified)
    Oct 1, 2023

    Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,

    Completed
    Has Results
    • Hemophagocytic Lymphohistiocytosis
    • +5 more
    • Hematopoietic Stem Cell Transplant
    • Birmingham, Alabama
    • +21 more
    Dec 6, 2022

    Renal Failure Trial in Chicago, Louisville (Enriched Hematopoietic Stem Cell Infusion)

    Active, not recruiting
    • Renal Failure
    • Enriched Hematopoietic Stem Cell Infusion
    • Chicago, Illinois
    • +1 more
    Jul 15, 2022

    Multiple Sclerosis Trial (hematopoetic stem cell infusion)

    Active, not recruiting
    • Multiple Sclerosis
    • hematopoetic stem cell infusion
    • (no location specified)
    Jul 15, 2022

    Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

    Active, not recruiting
    • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Oct 19, 2023